Bone marrow transplantation in major histocompatibility complex class II deficiency: A single-center study of 19 patients

Blood

Volumn 85, Issue 2, 1995, Pages 580-587

  Klein, Christoph ^a   Cavazzana Calvo, Marina ^a   Le Deist, Françoise ^a   Jabado, Nada ^a   Benkerrou, Malika ^a   Blanche, Stéphane ^a   Lisowska Grospierre, Barbara ^a   Griscelli, Claude ^a   Fischer, Alain ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; FEMALE; GENETIC COMPLEMENTATION; GENETIC REGULATION; HLA SYSTEM; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; INBORN ERROR OF METABOLISM; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; RECURRENT INFECTION; VIRUS INFECTION;

EID: 0028938632     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v85.2.580.580     Document Type: Article

References (34)

1. Griscelli C, Lisowska-Grospierre B, Mach B: Combined immunodeficiency with defective expression of MHC class II genes. Immunodef Rev 1:135, 1989
2. De Préval C, Lisowska-Grospierre B, Loche M, Griscelli C, Mach B: A transacting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature 318:291, 1985
3. Kara CJ, Glimcher LH: In vivo footprinting of MHC class II genes: Bare promoters in the bare lymphocyte syndrome. Science 252:709, 1991
4. Steimle V, Otten L, Zufferey M, Mach B: Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135, 1993
5. Van Eggermond MCJA, Rijkers GT, Kuis W, Zegers BJM, Van den Elsen PJ: T cell development in a major histocompatibility complex class II deficient patient. Eur J Immunol 23:2585, 1993
6. Klein C, Lisowska-Grospierre B, Le Deist F, Fischer A, Griscelli C: Major histocompatibility complex class II deficiency - Clinical manifestations, immunological features and outcome. J Pediatr 123:921, 1993
7. Lenarsky C, Parkman R: Bone marrow transplantation for the treatment of immune deficiency states. Bone Marrow Transplant 6:361, 1990
8. Fischer A, Durandy A, Vilmer E, Griscelli C: Bone marrow transplantation in a patient with HLA defective combined immunodeficiency, in Griscelli C, Vossen J (eds): Progress in Immunodeficiency Research and Therapy I. Amsterdam, The Netherlands, Excerpta Medical 1984, p 262
9. Casper JT, Ash RA, Kirchner P, Hunter JB, Havens PL, Chusid MJ: Successful treatment with an unrelated donor bone marrow transplant in an HLA-deficient patient with severe combined immunodeficiency ("bare lymphocyte syndrome"). J Pediatr 116:262, 1990
10. Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y: Microdroplet testing for HLA-A, -B, -C and -D antigens. Am J Clin Pathol 69:103, 1978
11. Marcadet A, Cohen D, Dausset J, Fischer A, Durandy A, Griscelli C: Genotyping with DNA probes in combined immunodeficiency syndrome with defective expression of HLA. N Engl J Med 312:1287, 1985
12. Fischer A, Griscelli C, Blanche S, Le Deist F, Veber F, Lopez M, Delaage M, Olive D, Maseur C, Janossy: Prevention of graft failure by anti-HLFA1 monoclonal antibody in HLA mismatched bone marrow transplantation. Lancet 2:1058, 1986
13. Jabado N, Thomas C, Cavazzano-Calvo M, Morgan G, Bujan W, Cant A, De Graeff-Meeders, Hale G, Benkerrou M, Fischer A: The use of two monoclonal antibodies (anti-LFA-1 CD11a, anti-CD2) in HLA non identical bone marrow transplantation in children with inherited disorders. 20th Annual Meeting of the European Group for Bone Marrow Transplantation (EBMT). Harrogate, London, March 1994 (abstr)
14. Fischer A, Durandy A, De Villartay JP, Vilmer E, Le Deist F, Gerota I, Griscelli C: HLA haploidentical bone marrow transplantation for severe combined immunodeficiency using E rosette fractionation and cyclosporine A. Blood 67:444, 1986
15. Hale G, Cobbold S, Waldmann H: T cell depletion with Campath-1 in allogeneic bone marrow transplantation. Transplantation 45:753, 1988
16. Herbelin C, Stephan JL, Donadieu J, Le Deist F, Racadot E, Wijdenes J, Fischer A: Treatment of steroid-resistant acute graftversus-host disease with an anti-IL-2-receptor monoclonal antibody (5BT 563) in children who received T cell-depleted, partially matched, related bone marrow transplants. Bone Marrow Transplant 13:563, 1994
17. Yam PJY, Petz LD, Knowlton RG, Wallace LB, Stock AD, de Lange G, Brown VA, Donis-Keller H, Blume KG: Use of DNA restriction fragment length polymorphism to document marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation. Transplantation 43:399, 1987
18. Glucksberg H, Storb R, Fefer A: Clinical manifestations of GVHD in human recipients of marrow from HLA matched sibling donors. Transplantation 18:295, 1974
19. Le Deist F, Thoenes G, Grospierre B, Fischer A: Immunodeficiency with low expression of T cell receptor-CD3 complex. Eur J Immunol 21:1641, 1991
20. Erkeller-Yuksel FM, Deneys V, Yuksel B, Hannet I, Hulstaart F, Hamilton C, Mackinnon H, Tumor-Stoker L, Munkyerhuli V, Vanlangendonck F, De Brujere M, Bach BA, Lydaard PM: Agerelated changes in human blood lymphocyte subpopulations. J Pediatr 120:216, 1992
21. Fischer A, Friedrich W, Levinsky R, et al: Bone marrow transplantation for immunodeficiencies and osteopetrosis: European survey 1968-1985. Lancet 2:1080, 1986
22. O'Reilly RY, Keever CA, Small TN, Brochstein J: The use of HLA non identical T-cell depleted marrow transplants for correction of SCID. Immunodef Rev 1:273, 1990
23. Fischer A, Landais P, Friedrich W, Gerritsen B, Fasth A, Porta F, Vellodi A, Benkerrou M, Cavazzano-Calvo M, Souillet G, Bordigoni P, Morgan G, Van Dijken P, Vossen J, Locatelli F, Di Bartolomeo P: Bone marrow transplantation in Europe for primary immunodeficiencies other than severe combined immunodeficiency. An EBMT/EGID report. Blood 83:1149, 1994
24. Rieux-Laucat F, Le Deist F, Selz F, Fischer A, de Villartay JP: Normal T cell Vbeta usage in a primary immunodeficiency associated with HLA class II deficiency. Eur J Immunol 23:928, 1993
25. Knobloch C, Ballas M, Wölpl A, Friedrich W: Allorecognition and T cell repertoire selection in severe combined immunodeficiency lacking HLA class II antigens. Transplantation 53:1295, 1992
26. Fischer A, Friedrich W, Fasth A, Blanche S, Le Deist F, Girault D, Veber F, Vossen J, Lopez M, Griscelli C, Hirn M: Reduction of graft failure by a monoclonal antibody (anti-FLA-1 CD11) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: A European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report. Blood 77:249, 1991
27. Drobyski WR, Dunne WM, Burd EM, Knox KK, Ash RC, Horowitz MM, Flomenberg N, Carrigan DR: Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: Evidence of a marrow-suppressive role for HHV in vivo. J Infect Dis 167:735, 1993
28. Buckley RH, Schiff SE, Sampson HA, Schiff RI, Market ML, Knutsen AP, Hershfield MS, Huang AT, Mickey GH, Ward FE: Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol 136:2398, 1986
29. Dror Y, Gallagher R, Wara DW, Colombe BW, Merino A, Benkerrou M, Cowan MJ: Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation. Blood 81:2021, 1993
30. Grusby MJ, Johnson RS, Papaioannou VE, Glimcher LH: Deletion of CD4+ T cells in major histocompatibility complex class II deficient mice. Science 253:1417, 1991
31. Cosgrove D, Gray D, Dierich A, Kaufman J, Lemeur M, Benoist C, Mathis D: Mice lacking MHC class II molecules. Cell 66:1061, 1991
32. Schuurman HJ, van de Wijngaert FP, Huber J, Schuurman RKB, Zegers BJM, Roord JJ, Kater L: The thymus in "bare lymphocyte syndrome." Significance of expression of MHC antigens on thymic epithelial cells in intrathymic T cell maturation. Hum Immunol 13:69, 1985
33. Kisielow P, Teh HS, Bluthmann H, von Boehmer H: Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature 335:730, 1988
34. Blaese RM, Culver KW: Gene therapy for primary immunodeficiency disease. Immunodef Rev 3:329, 1992